Skip to main content

Kaan Boztug receives the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"


Kaan Boztug, St. Anna Children's Cancer Research (Photographer: Ian Ehm).

Congratulations to Kaan Boztug, Scientific Director of the St. Anna Children's Cancer Research Institute, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases and CeMM Adjunct Principal Investigator, who has been awarded the Işil Berat Barlan Award for his outstanding research in the field of primary immunodeficiencies, which will be presented for the first time this year at the European Congress of Immunology (ECI).

The scientist receives this award for his pioneering research on immunodeficiencies. Disturbances in the balance of the immune system can be the starting point for a number of diseases such as increased susceptibility to infections, autoimmune diseases and cancer. The study of congenital defects of the immune system makes it possible to uncover the molecular mechanisms underlying such severe diseases. This forms the basis for new effective treatment approaches.

"I have been very fortunate to meet Prof. Işil Berat Barlan personally and to have the opportunity to work with her. Therefore, this award has a very special meaning for me. I see this award in memory of Prof. Barlan as a wonderful way to honor her life and her many achievements in pediatrics and immunology - so I am particularly pleased to receive this award," says Kaan Boztug.

About the award           

Every year since 2016, the Turkish Society of Immunology (TSI), together with Prof. Talal Chatila of Harvard Medical School, present this award in honor of Prof. Işil Berat Barlan, a distinguished physician-scientist and an educator that made invaluable contributions in the fields of Allergy and Immunology in Turkey and internationally.

More information: